To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dua ...

One in five older adults gets an infection up to six months after heart surgery—with women far more likely to develop one, ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Driven by rising rates of high blood pressure, obesity, and other key risk factors, heart disease remains the leading cause ...

One in five older adults gets an infection up to six months after heart surgery - with women far more likely to develop one, ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

One of the biggest challenges in managing AAA and PAD is the unpredictability of disease progression. For instance, while ...

This year, rolling out had the privilege of attending Morehouse School of Medicine’s 50th-anniversary Men’s Health Breakfast, ...

WVU Medicine Camden Clark Medical Center has earned the HeartCARE Center National Distinction of Excellence from the American ...